CenExel Clinical Research, Inc., announced the creation of their Centers of Excellence company, which unites clinical research units to design and execute Phase I-IV trials, including Phase I studies in patient populations, to help pharmaceutical companies improve the time and cost of new therapy development for better patient care.
CenExel operates in Utah, California, Georgia and Maryland.
The CenExel Centers of Excellence include JBR Clinical Research, Atlanta Center for Medical Research (ACMR), Anaheim Clinical Trials (ACT), and CBH Health, research facilities in respective fields: post-operative pain, central nervous system (CNS) disorders, chronic disease management, Asian pharmacokinetic bridging studies, psychiatric illnesses, and others.
"CenExel Centers of Excellence offer pharmaceutical companies and clinical research organizations access to some of the finest investigators and facilities in the world for conducting research," said Tom Wardle, CEO. "We are focused on delivering the highest possible quality through our combined expertise, the engagement of our investigators and staff, and most importantly, our results."
Their principal investigators include Todd Bertoch, MD, Robert A. Reisenberg, MD, Peter Winkle, MD, and Robert E. Litman, MD. Dr. Bertoch also chairs the CenExel Scientific Advisory Board with noted analgesia research experts Stephen Cooper, DMD, PhD, and Paul Desjardins, DMD, PhD.
Kevin Quinn, VP of Business Development and Integration, said, "The level of engagement among staff and patients is a key differentiator with our Centers of Excellence. This commitment has enabled our Centers to routinely meet or exceed patient recruitment goals in hundreds of clinical trials, so we are able to complete studies on-time and within budget."
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Using Patient Reported Outcomes in Dermatology Trials
April 25th 2024In part 3 of this video interview with ACT editor Andy Studna, Melissa Mooney, director, eCOA sales engineering, IQVIA sheds light on the unique challenges of dermatology trials and how clinical outcome assessments can be implemented in them.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.